Stocktoria

ANI PHARMACEUTICALS INC ANIP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2000-05-04 · LEI

ANI PHARMACEUTICALS INC statistics & valuation

Market cap$1.9B
P / E24.5×
P / S2.2×
P / B3.6×
P / FCF11.2×
Dividend yield0.06%
Net margin8.9%
Return on equity14.5%
FCF margin19.4%
Net debt$6.3M
Enterprise value USD$1.9B
EV / EBITDA9.5×
Earnings yield EBIT/EV5.8%
Return on capital9.6%
Graham number -43.6%$42.38

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($42.38); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
3.10% -0.60% 7.70% 3.00% -10.80% -19.70% -15.10% 3.90% -3.00% 8.90% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
15.60% 16.00% 17.50% 7.90% -7.70% -18.40% -11.20% 9.60% 0.10% 12.60% 2016201720182019202020212022202320242025
Return on equity (%)
2.30% -0.60% 7.90% 2.90% -11.50% -12.80% -15.30% 4.30% -4.60% 14.50% 2016201720182019202020212022202320242025
Shares outstanding
11.6M 11.5M 11.8M 12.0M 12.0M 12.6M 16.3M 18.2M 21.1M 22.5M 2016201720182019202020212022202320242025
Net debt ($)
$93.3M $97.1M $24.3M $113.5M $164.6M $186.2M $237.4M $63.7M $164.2M $6.3M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
1.20% -0.30% 3.60% 1.30% -4.90% -5.50% -6.30% 2.10% -1.40% 5.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
17.80% 16.40% 30.40% 18.90% 4.40% 0.40% -12.70% 22.60% 7.80% 19.40% 2016201720182019202020212022202320242025
Debt / equity (×)
0.71× 0.73× 0.34× 0.83× 0.88× 0.86× 0.91× 0.66× 0.77× 0.54× 2016201720182019202020212022202320242025
EPS ($)
$0.34 -$0.09 $1.30 $0.50 -$1.88 -$3.40 -$3.05 $0.85 -$1.04 $3.32 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

ANI PHARMACEUTICALS INC trades at about 22.6× earnings — below its 10-year norm (10-year range 21.6×–177.8×, median 41.3×).

21.6× 177.8×

Shaded band = 10-year range (21.6×–177.8×); dot = today's 22.6×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin12.6%0.1%9.6%-11.2%-18.4%-7.7%7.9%17.5%16.0%15.6%
Net margin8.9%-3.0%3.9%-15.1%-19.7%-10.8%3.0%7.7%-0.6%3.1%
FCF margin19.4%7.8%22.6%-12.7%0.4%4.4%18.9%30.4%16.4%17.8%
Return on assets5.4%-1.4%2.1%-6.3%-5.5%-4.9%1.3%3.6%-0.3%1.2%
Return on equity14.5%-4.6%4.3%-15.3%-12.8%-11.5%2.9%7.9%-0.6%2.3%
Debt / equity0.54×0.77×0.66×0.91×0.86×0.88×0.83×0.34×0.73×0.71×
Current ratio2.712.723.573.463.682.173.040.923.353.22

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.